000 10143nam a22005053i 4500
001 EBC4556283
003 MiAaPQ
005 20191126091727.0
006 m o d |
007 cr cnu||||||||
008 191125s2016 xx o ||||0 eng d
020 _a9781118993613
_q(electronic bk.)
020 _z9781118993620
035 _a(MiAaPQ)EBC4556283
035 _a(Au-PeEL)EBL4556283
035 _a(CaPaEBR)ebr11222751
035 _a(CaONFJC)MIL933653
035 _a(OCoLC)951678273
040 _aMiAaPQ
_beng
_erda
_epn
_cMiAaPQ
_dMiAaPQ
050 4 _aR119.9 -- .W574 2016eb
082 0 _a610.28499999999997
100 1 _aEshaghian-Wilner, Mary Mehrnoosh.
_938532
245 1 0 _aWireless Computing in Medicine :
_bFrom Nano to Cloud with Ethical and Legal Implications.
250 _a1st ed.
264 1 _aHoboken :
_bJohn Wiley & Sons, Incorporated,
_c2016.
264 4 _c©2016.
300 _a1 online resource (758 pages)
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aNature-Inspired Computing Ser.
505 0 _aIntro -- TITLE PAGE -- TABLE OF CONTENTS -- CONTRIBUTORS -- FOREWORD -- PREFACE -- PART I: INTRODUCTION -- 1 INTRODUCTION TO WIRELESS COMPUTING IN MEDICINE -- 1.1 INTRODUCTION -- 1.2 DEFINITION OF TERMS -- 1.3 BRIEF HISTORY OF WIRELESS HEALTHCARE -- 1.4 WHAT IS WIRELESS COMPUTING? -- 1.5 DISTRIBUTED COMPUTING -- 1.6 NANOTECHNOLOGY IN MEDICINE -- 1.7 ETHICS OF MEDICAL WIRELESS COMPUTING -- 1.8 PRIVACY IN WIRELESS COMPUTING -- 1.9 CONCLUSION -- REFERENCES -- 2 NANOCOMPUTING AND CLOUD COMPUTING -- 2.1 INTRODUCTION -- 2.2 NANOCOMPUTING -- 2.3 CLOUD COMPUTING -- 2.4 CONCLUSION -- ACKNOWLEDGMENT -- REFERENCES -- PART II: PERVASIVE WIRELESS COMPUTING IN MEDICINE -- 3 PERVASIVE COMPUTING IN HOSPITALS -- 3.1 INTRODUCTION -- 3.2 ARCHITECTURE OF PERVASIVE COMPUTING IN HOSPITALS -- 3.3 SENSORS, DEVICES, INSTRUMENTS, AND EMBEDDED SYSTEMS -- 3.4 DATA ACQUISITION IN PERVASIVE COMPUTING -- 3.5 SOFTWARE SUPPORT FOR CONTEXT‐AWARE AND ACTIVITY SHARING SERVICES -- 3.6 DATA AND INFORMATION SECURITY -- 3.7 CONCLUSION -- ACKNOWLEDGMENT -- REFERENCES -- 4 DIAGNOSTIC IMPROVEMENTS -- 4.1 INTRODUCTION -- 4.2 SYSTEM DESIGN -- 4.3 BODY SENSOR NETWORK -- 4.4 PORTABLE SENSORS -- 4.5 WEARABLE SENSORS -- 4.6 IMPLANTABLE SENSORS -- 4.7 WIRELESS COMMUNICATION -- 4.8 MOBILE BASE UNIT -- 4.9 CONCLUSION AND CHALLENGES -- ACKNOWLEDGMENT -- REFERENCES -- 5 COLLABORATIVE OPPORTUNISTIC SENSING OF HUMAN BEHAVIOR WITH MOBILE PHONES -- 5.1 HEALTH AND MOBILE SENSING -- 5.2 THE InCense SENSING TOOLKIT -- 5.3 SENSING CAMPAIGN 1: DETECTING BEHAVIORS ASSOCIATED WITH THE FRAILTY SYNDROME AMONG OLDER ADULTS -- 5.4 SENSING CAMPAIGN 2: DETECTING PROBLEMATIC BEHAVIORS AMONG ELDERS WITH DEMENTIA -- 5.5 DISCUSSION -- 5.6 CONCLUSIONS AND FUTURE WORK -- REFERENCES -- 6 PERVASIVE COMPUTING TO SUPPORT INDIVIDUALS WITH COGNITIVE DISABILITIES -- 6.1 INTRODUCTION.
505 8 _a6.2 WEARABLE AND MOBILE SENSING PLATFORMS TO EASE THE RECORDING OF DATA RELEVANT TO CLINICAL CASE ASSESSMENT -- 6.3 AUGMENTED REALITY AND MOBILE AND TANGIBLE COMPUTING TO SUPPORT COGNITION -- 6.4 SERIOUS GAMES AND EXERGAMES TO SUPPORT MOTOR IMPAIRMENTS -- 6.5 CONCLUSIONS -- ACKNOWLEDGMENTS -- REFERENCES -- 7 WIRELESS POWER FOR IMPLANTABLE DEVICES -- 7.1 INTRODUCTION -- 7.2 HISTORY OF WIRELESS POWER -- 7.3 APPROACH OF WIRELESS POWER TRANSMISSION -- 7.4 A DETAILED EXAMPLE OF MAGNETIC COUPLING RESONANCE -- 7.5 POPULAR STANDARDS -- 7.6 WIRELESS POWER TRANSMISSION IN MEDICAL USE -- 7.7 CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- 8 ENERGY‐EFFICIENT PHYSICAL ACTIVITY DETECTION IN WIRELESS BODY AREA NETWORKS -- 8.1 INTRODUCTION -- 8.2 KNOWME PLATFORM -- 8.3 ENERGY IMPACT OF DESIGN CHOICES -- 8.4 PROBLEM FORMULATION -- 8.5 SENSOR SELECTION STRATEGIES -- 8.6 ALTERNATIVE PROBLEM FORMULATION -- 8.7 SENSOR SELECTION STRATEGIES FOR THE ALTERNATIVE FORMULATION -- 8.8 EXPERIMENTS -- 8.9 RELATED WORK -- 8.10 CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- 9 MARKOV DECISION PROCESS FOR ADAPTIVE CONTROL OF DISTRIBUTED BODY SENSOR NETWORKS -- 9.1 INTRODUCTION -- 9.2 RATIONALE FOR MDP FORMULATION -- 9.3 RELATED WORK -- 9.4 PROBLEM STATEMENT, ASSUMPTIONS, AND APPROACH -- 9.5 MDP MODEL FOR MULTIPLE SENSOR NODES -- 9.6 COMMUNICATION -- 9.7 SIMULATION RESULTS -- 9.8 CONCLUSIONS -- ACKNOWLEDGMENT -- REFERENCES -- PART III: NANOSCALE WIRELESS COMPUTING IN MEDICINE -- 10 AN INTRODUCTION TO NANOMEDICINE -- 10.1 INTRODUCTION -- 10.2 NANOMEDICAL TECHNOLOGY -- 10.3 DETECTION -- 10.4 TREATMENT -- 10.5 BIOCOMPATIBILITY -- 10.6 POWER -- 10.7 COMPUTER MODELING -- 10.8 RESEARCH INSTITUTIONS -- 10.9 CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- 11 NANOMEDICINE USING MAGNETO‐ELECTRIC NANOPARTICLES -- 11.1 INTRODUCTION -- 11.2 OVERVIEW OF MENs.
505 8 _a11.3 EXPERIMENT 1: EXTERNALLY CONTROLLED ON‐DEMAND RELEASE OF ANTI‐HIV DRUG AZTTP USING MENS AS CARRIERS -- 11.4 EXPERIMENT 2: MENS TO ENABLE FIELD‐CONTROLLED HIGH‐SPECIFICITY DRUG DELIVERY TO ERADICATE OVARIAN CANCER CELLS -- 11.5 EXPERIMENT 3: MAGNETOELECTRIC "SPIN" ON STIMULATING THE BRAIN -- 11.6 BIOCERAMICS: BONE REGENERATION AND MNS -- 11.7 CONCLUSION -- REFERENCES -- 12 DNA COMPUTATION IN MEDICINE -- 12.1 BACKGROUND FOR THE NON‐BIOLOGIST -- 12.2 INTRODUCTION -- 12.3 IN VITRO COMPUTING -- 12.4 COMPUTATION IN VIVO -- 12.5 CHALLENGES -- 12.6 GLIMPSE INTO THE FUTURE -- REFERENCES -- 13 GRAPHENE‐BASED NANOSYSTEMS FOR the DETECTION OF PROTEINIC BIOMARKERS OF DISEASE -- 13.1 INTRODUCTION -- 13.2 STRUCTURAL AND PHYSICOCHEMICAL PROPERTIES OF GRAPHENE AND MAIN DERIVATIVES -- 13.3 GRAPHENE AND DERIVATIVES‐BASED BIOSENSING NANOSYSTEMS AND APPLICATIONS -- 13.4 CONCLUSION AND PERSPECTIVES -- CONFLICT OF INTEREST -- REFERENCES -- 14 MODELING BRAIN DISORDERS IN SILICON NANOTECHNOLOGIES -- 14.1 INTRODUCTION -- 14.2 THE BioRC PROJECT -- 14.3 BACKGROUND: BioRC NEURAL CIRCUITS -- 14.4 MODELING SYNAPSES WITH CNT TRANSISTORS -- 14.5 MODELING OCD WITH HYBRID CMOS/NANO CIRCUITS -- 14.6 THE BIOLOGICAL CORTICAL NEURON AND HYBRID ELECTRONIC CORTICAL NEURON -- 14.7 BIOLOGICAL OCD CIRCUIT AND BIOMIMETIC MODEL -- 14.8 INDIRECT PATHWAY: THE BRAKING MECHANISM -- 14.9 DIRECT PATHWAY: THE ACCELERATOR -- 14.10 TYPICAL AND ATYPICAL RESPONSES -- 14.11 MODELING SCHIZOPHRENIC HALLUCINATIONS WITH HYBRID CMOS/NANO CIRCUITS -- 14.12 EXPLANATION FOR SCHIZOPHRENIA SYMPTOMS -- 14.13 DISINHIBITION DUE TO MISWIRING -- 14.14 OUR HYBRID NEUROMORPHIC PREDICTION NETWORK -- 14.15 SIMULATION RESULTS -- 14.16 NUMERICAL ANALYSIS OF FALSE FIRING -- 14.17 MODELING PD WITH CMOS CIRCUITS -- 14.18 MODELING MS WITH CMOS CIRCUITS -- 14.19 DEMYELINATION CIRCUIT -- 14.20 CONCLUSIONS AND FUTURE TRENDS.
505 8 _aREFERENCES -- 15 LINKING MEDICAL NANOROBOTS TO PERVASIVE COMPUTING -- 15.1 INTRODUCTION -- 15.2 COMPLEMENTARY FUNCTIONALITIES -- 15.3 MAIN SPECIFICATIONS FOR SUCH NANOROBOTIC AGENTS (NANOROBOTS) -- 15.4 MEDICAL NANOROBOTIC AGENTS-AN EXAMPLE -- 15.5 NANOROBOTIC COMMUNICATION LINKS ALLOWING PERVASIVE COMPUTING -- 15.6 TYPES OF INFORMATION -- 15.7 MEDICAL NANOROBOTIC AGENTS FOR MONITORING AND EARLY DETECTION -- 15.8 MEDICAL NANOROBOTICS AND PERVASIVE COMPUTING-MAIN CONDITIONS THAT MUST BE MET FOR ITS FEASIBILITY -- 15.9 CONCLUSION -- REFERENCES -- 16 NANOMEDICINE'S TRANSVERSALITY -- 16.1 INTRODUCTION -- 16.2 NANOMEDICINE'S PROMISES -- 16.3 ANALYSING IMPLICATIONS OF THE NANOMEDICINE PARADIGM -- 16.4 THE MOLECULAR UNDERPINNINGS OF NANOMEDICINE'S TRANSVERSALITY -- 16.5 NANOMEDICINE AS PREDICTIVE MEDICINE -- 16.6 NANOMEDICINE AS PERSONALIZED MEDICINE -- 16.7 NANOMEDICINE AS REGENERATIVE MEDICINE -- 16.8 CONCLUSION -- REFERENCES -- PART IV: ETHICAL AND LEGAL ASPECTS OF WIRELESS COMPUTING IN MEDICINE -- 17 ETHICAL CHALLENGES OF UBIQUITOUS HEALTH CARE* -- 17.1 INTRODUCTION -- 17.2 A PHILOSOPHICAL FRAMEWORK -- 17.3 INFORMATION DEVIANCE -- 17.4 THE CURRENT FRENZY -- 17.5 GENETIC INFORMATICS -- 17.6 UBIQUITOUS INFORMATION TECHNOLOGY -- 17.7 STASIS VERSUS PROGRESS -- 17.8 PROBLEMATIC ETHICS -- 17.9 LEADERSHIP IN SCIENCE AND ENGINEERING ETHICS -- 17.10 CONCLUSION -- REFERENCES -- 18 THE ETHICS OF UBIQUITOUS COMPUTING IN HEALTH CARE -- 18.1 INTRODUCTION -- 18.2 UBIQUITOUS COMPUTING AND THE TRANSFORMATION OF HEALTH CARE: THREE VISIONS -- 18.3 CASE STUDY: CARDIAC IMPLANTED ELECTRICAL DEVICES -- 18.4 ETHICAL REFLECTIONS -- 18.5 CONCLUSIONS: THE NEED FOR SOCIO‐TECHNICAL DESIGN -- REFERENCES -- 19 PRIVACY PROTECTION OF ELECTRONIC HEALTHCARE RECORDS IN e‐HEALTHCARE SYSTEMS -- 19.1 INTRODUCTION -- 19.2 SECURITY AND PRIVACY CONCERNS OF EHR IN e‐HEALTHCARE SYSTEMS.
505 8 _a19.3 PRIVACY LAWS AND REGULATIONS OF EHRs -- 19.4 PRIVACY OF EHRs IN e‐HEALTHCARE SYSTEMS -- 19.5 DISCUSSION AND CONCLUSION -- 19.6 CONTRIBUTIONS AND FUTURE RESEARCH -- REFERENCES -- 20 ETHICAL, PRIVACY, AND INTELLECTUAL PROPERTY ISSUES IN NANOMEDICINE -- 20.1 INTRODUCTION -- 20.2 ETHICAL ISSUES -- 20.3 PRIVACY ISSUES -- 20.4 IP ISSUES -- 20.5 CONCLUSION -- ACKNOWLEDGMENTS -- REFERENCES -- PART V: CONCLUSION -- 21 CONCLUDING REMARKS -- 21.1 WIRELESS COMPUTING IN HEALTH CARE -- 21.2 NANOMEDICINE -- 21.3 ETHICAL, PRIVACY, AND INTELLECTUAL PROPERTY ISSUES OF NANOMEDICINE AND WIRELESS COMPUTING -- 21.4 CONCLUSIONS -- ACKNOWLEDGMENTS -- REFERENCES -- INDEX -- END USER LICENSE AGREEMENT.
588 _aDescription based on publisher supplied metadata and other sources.
590 _aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2019. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 0 _aTelecommunication in medicine--Moral and ethical aspects.
_938533
655 4 _aElectronic books.
_938534
776 0 8 _iPrint version:
_aEshaghian-Wilner, Mary Mehrnoosh
_tWireless Computing in Medicine : From Nano to Cloud with Ethical and Legal Implications
_dHoboken : John Wiley & Sons, Incorporated,c2016
_z9781118993620
797 2 _aProQuest (Firm)
830 0 _aNature-Inspired Computing Ser.
_938535
856 4 0 _uhttps://ebookcentral.proquest.com/lib/thebc/detail.action?docID=4556283
_zClick to View
887 _aEBK
942 _cEBK
999 _c72900
_d72900